Greenwich LifeSciences, Inc. (GLSI) stock

GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 5/30

$14.94−0.34 (-2.23%)

Close on Nov 13, 2026Market cap $219.29MP/E –Yield –

Greenwich LifeSciences statistics

59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $219.29M; $272.32M
Enterprise Value: $210.42M; $146.23M
PB Ratio: 70.35; 2.00
P/TBV Ratio: 70.35; 2.22

Share statisticsIndustry

Shares Outstanding: 15M; 58M
Shares Change (YoY): 7.47%; 10.8%
Shares Change (QoQ): 0.08%; 0.50%
Float: 4M; 49M
Shares Held by Insiders: 70.9%; 11.7%
Shares Held by Institutions: 11.5%; 56.4%

Short sellingIndustry

Short Interest: 2M; –
Short Interest Change: 1.66%; -0.80%
Short % of Float: 36.9%; 9.01%
Short % of Shares Outstanding: 10.8%; 6.30%
Days to Cover: 12.51; 5.15

Stock price statisticsIndustry

52-Week High: $34.10; –
52-Week Low: $7.78; –
20-Day Moving Average: $16.31; –
50-Day Moving Average: $16.57; –
200-Day Moving Average: $20.99; –
Average True Range (14): $1.40; –
Price Change (1 Week): -1.52%; -1.15%
Price Change (1 Month): -2.48%; -4.87%
Price Change (3 Months): -14.0%; -21.0%
Price Change (6 Months): -45.1%; -20.6%
Price Change (YTD): -28.9%; -23.6%
Price Change (1 Year): 79.5%; -22.4%
Price Change (3 Years): 43.0%; -29.5%
Price Change (5 Years): -58.0%; -77.9%
Average Volume (10 Days): 129,525; –
Average Volume (20 Days): 129,299; –
Average Volume (90 Days): 137,925; –
Relative Volume: 0.54; 0.70
Relative Strength Index (14): 43.2; 43.4
Volatility (1 Year): 105.9%; 80.1%
Beta (5 Years): 1.54; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -1207.7%; -49.9%
Return on Assets (ROA): -374.5%; -40.6%
Return on Capital Employed (ROCE): -701.6%; -37.9%

Financial positionIndustry

Current Ratio: 1.54; 3.30
Quick Ratio: 1.54; 2.39

EfficiencyIndustry

Profits Per Employee: -$5.62M; -$689.41K
Employee Count: 4; 74
WACC: 12.8%; 10.2%

Income statement (TTM)Industry

Operating Income: -$21.87M; -$21.37M
Net Income: -$22.47M; -$22.35M
EBITDA: -$21.87M; -$17.21M
EPS (Diluted): -$1.59; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $8.88M; $68.68M
Net Cash (Debt): $8.88M; $17.76M
Net Cash Per Share: $0.60; $0.80
Equity (Book Value): $3.12M; $53.89M
Book Value Per Share: $0.21; $1.50
Tangible Book Value: $3.12M; $27.13M
Working Capital: $3.12M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$12.49M; -$12.38M

Dividends and yieldsIndustry

Earnings Yield: -10.2%; -21.8%

Scores and fair valueIndustry

Altman Z-Score: -0.12; 0.23
Piotroski F-Score: 2; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	GLSI	S&P 500	Difference	GLSI per year	S&P 500 per year
1 month	-3.6%	-3.0%	−0.6 pts
3 months	-8.8%	-2.8%	−6.0 pts
Year to date	-28.9%	+11.5%	−40.4 pts
1 year	+82.2%	+13.5%	+68.7 pts
3 years	+45.2%	+77.7%	−32.5 pts	+13.2%	+21.1%
5 years	-58.0%	+72.6%	−130.6 pts	-15.9%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M GLSI shares were sold short on Oct 30, 2026, up 1.7% from the previous report, or 36.94% of the shares available to trade. At recent volumes it would take 12.5 days to buy them back. Over the last 20 sessions, 66.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	1,578,166	+1.7%	126,122	12.5
Oct 15, 2026	1,552,366	-1.8%	144,878	10.7
Sep 30, 2026	1,580,950	-3.1%	138,983	11.4
Sep 15, 2026	1,631,150	-1.8%	82,446	19.8
Aug 31, 2026	1,660,969	+4.2%	146,322	11.3
Aug 14, 2026	1,593,720	+3.4%	120,106	13.3
Jul 31, 2026	1,541,345	+5.0%	214,552	7.2
Jul 15, 2026	1,467,739	+0.7%	121,146	12.1
Jun 30, 2026	1,458,039	-0.2%	168,898	8.6
Jun 15, 2026	1,461,511	-3.7%	162,024	9.0
May 29, 2026	1,518,228	-1.5%	113,576	13.4
May 15, 2026	1,541,786	-0.2%	139,854	11.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?